Abcam PLC Financials

Abcam PLC Stock Summary

Abcam PLC competes with Anebulo Pharmaceuticals, Adagene, Acrivon Therapeutics,, AnaptysBio, and Mineralys Therapeutics,. Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. Abcam Plc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1682 people.

Abcam PLC Key Financial Ratios

Abcam Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Abcam PLC's current stock value. Our valuation model uses many indicators to compare Abcam PLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abcam PLC competition to find correlations between indicators driving Abcam PLC's intrinsic value. More Info.Abcam PLC is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  12.46  of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all technique that is used if you cannot value Abcam PLC by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

If you are still planning to invest in Abcam PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Abcam PLC's history and understand the potential risks before investing.